TNFAIP3 and treatment resistant depression: Kang et al. [65] analyzed genetic predictors of ketamine response in patients with TRD, reporting novel associations in genes regulating synaptic vesicle trafficking (SYNGR1, VAMP2) and immune regulation (IL6R, TNFAIP3).